Epidemiology of Bloodstream Infections and Impact of Antibiotic Prophylaxis: A 10-Year Experience at a Tertiary Care Pediatric Oncology-Hematology Center in Italy
Bloodstream infections (BSIs) are a leading cause of morbidity and mortality in pediatric oncology-hematology patients. The local epidemiological landscape varies across centers, requiring continuous institutional surveillance. BSI episodes at a tertiary pediatric oncology-hematology center (Bari, Italy) were retrospectively reviewed over 10 years (2014 to 2024), analyzing microbiological spectrum, antimicrobial susceptibility, and the impact of 2 prophylactic policies: amoxicillin-clavulanate prophylaxis (2014 to 2019) versus its discontinuation (2019 to 2024). Among 568 newly diagnosed patients, 208 BSIs were documented in 144 (25.4%), with 93.8% monomicrobial. Gram-positive organisms predominated (61.6%), with coagulase-negative staphylococci as the most frequent isolates. Escherichia coli was the leading Gram-negative pathogen (9.5%). Eight fungal BSIs occurred exclusively in hematologic malignancies, half caused by Candida parapsilosis ; 2 were polymicrobial. Peak C-reactive protein independently predicted Gram-negative BSI in multivariable analysis (OR: 1.005; 95% CI: 1.001-1.010; P <0.05), with limited discriminatory performance (AUC: 0.62). Blood culture positivity was significantly higher during prophylaxis (5.75% vs. 3.65%; P <0.001). Multidrug-resistant organisms remained rare (3.8%), with no methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci detected. BSI-related mortality was 1.4%, confined to Gram-negative and fungal episodes. Prophylaxis discontinuation was associated with lower positivity rates. An empirical escalation strategy ensured adequate coverage while minimizing antibiotic exposure, supporting its use in this setting.
Authors
- Elio Castagnola (ORCID: https://orcid.org/0000-0002-5336-8429)
- Nicola Santoro (ORCID: https://orcid.org/0000-0001-8853-6536)
- Francesco De Leonardis (ORCID: https://orcid.org/0000-0001-5801-7225)
- Luigi Ronga (ORCID: https://orcid.org/0000-0001-8941-328X)
- Paola Muggeo (ORCID: https://orcid.org/0000-0001-8813-3200)
- Chiara Novielli (ORCID: https://orcid.org/0000-0002-3570-8290)
- Maria Chironna (ORCID: https://orcid.org/0000-0002-1043-1256)
- Roberta Koronica (ORCID: https://orcid.org/0009-0005-2088-1305)
- Valentina Erroi
- Roberta Rando (ORCID: https://orcid.org/0009-0009-6710-2267)
Institutions
- Istituto Giannina Gaslini (IT)
- Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari (IT)
- Ospedale Pediatrico Giovanni XXIII (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Journal of Pediatric Hematology/Oncology
- Published
- 2026-11-17
- DOI
- https://doi.org/10.1097/mph.0000000000003323
- Primary Topic
- Neutropenia and Cancer Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00